August 2023
Sacks Parente Places Bet on Golf’s Future
Sacks Parente Golf Inc., a manufacturer of golf equipment based in Camarillo, is reeling from an over-par debut on the New York Stock Exchange. The maker of a $400 putter saw its stock price soar on Aug. 15, its first day of trading, but the bliss was short-lived. Sacks Parente shares tumbled 80% the following […]
Noteefy Wants to Help Golfers Play More Rounds
In sunny Southern California, it can be hard for golfers to schedule tee times on their favorite courses. While spots are coveted, if tee times are canceled or open reservation times aren’t noticed, golf courses can lose out on a substantial amount of revenue. Enter Noteefy, a tee time-reservation and booking platform that has experienced […]
Mythical Pivots to Transactions
Mythical Inc. is putting game development on the back burner as it leans into establishing itself as a provider of gaming infrastructure for other companies. The Sherman Oaks-based company has been focused on blockchain and web3 technology since its founding, and is now using proprietary technology from two recent acquisitions to support cloud gaming and […]
Xsolla’s ‘Parental Control’ Seeks Online Protection
Xsolla is partnering with identity-management company Privo Inc. to release a new feature called Parental Control. The goal is to protect child privacy online. Xsolla, a video game commerce company based in Sherman Oaks, offers a suite of products to help developers market, distribute and monetize their games, and its clients include Twitch, Ubisoft, Epic […]
Hospitals Get Top Ratings for Quality
Three San Fernando Valley-area hospitals have received five-star quality rating from the federal Centers for Medicare and Medicaid Services agency. The hospitals – Glendale Adventist Medical Center, Northridge Hospital Medical Center and Providence Holy Cross Medical Center in Mission Hills – placed in the top ranks of the agency’s annual quality-ratings survey released last month. […]
Amgen CEO Decries Federal Deliberations
Robert Bradway, chief executive of Thousand Oaks pharma giant Amgen Inc., has grown increasingly frustrated at the government’s unwillingness to come to terms with Amgen over its $27.8 billion acquisition deal of Irish pharma company Horizon Therapeutics. That deal, announced last December, hit a major stumbling block in May when the Federal Trade Commission filed […]